Characteristics and management of primary and other immune thrombocytopenias: Spanish registry study

References

• Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009;113:2386–2393. doi: 10.1182/blood-2008-07-162503
   PubMed Web of Science ®Google Scholar
• Segal JB, Powe NR. Prevalence of immune thrombocytopenia: analyses of administrative data. J Thromb Haemost. 2006;4:2377–2383. doi: 10.1111/j.1538-7836.2006.02147.x
   PubMed Web of Science ®Google Scholar
• Terrell DR, Beebe LA, Vesely SK, et al. The incidence of immune thrombocytopenic purpura in children and adults: a critical review of published reports. Am J Hematol. 2010;85:174–180. doi: 10.1002/ajh.21833
   PubMed Web of Science ®Google Scholar
• Frederiksen H, Schmidt K. The incidence of idiopathic thrombocytopenic purpura in adults increases with age. Blood. 1999;94:909–913.
   PubMed Web of Science ®Google Scholar
• Neylon AJ, Saunders PWG, Howard MR, et al. Clinically significant newly presenting autoimmune thrombocytopenic purpura in adults: a prospective study of a population-based cohort of 245 patients. Br J Haematol. 2003;122:966–974. doi: 10.1046/j.1365-2141.2003.04547.x
   PubMed Web of Science ®Google Scholar
• Chong BH, Ho S-J. Autoimmune thrombocytopenia. J Thromb Haemost. 2005;3:1763–1772. doi: 10.1111/j.1538-7836.2005.01376.x
   PubMed Web of Science ®Google Scholar
• McMillan R. Autoantibodies and autoantigens in chronic immune thrombocytopenic purpura. Semin Hematol. 2000;37:239–248. doi: 10.1016/S0037-1963(00)90102-1
   PubMed Web of Science ®Google Scholar
• Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Engl J Med. 2002;346:995–1008. doi: 10.1056/NEJMra010501
   PubMed Web of Science ®Google Scholar
• Ballem PJ, Segal GM, Stratton JR, et al. Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura. Evidence of both impaired platelet production and increased platelet clearance. J Clin Invest. 1987;80:33–40. doi: 10.1172/JCI113060
   PubMed Web of Science ®Google Scholar
• Houwerzijl EJ, Blom NR, van der Want JJL, et al. Ultrastructural study shows morphologic features of apoptosis and para-apoptosis in megakaryocytes from patients with idiopathic thrombocytopenic purpura. Blood. 2004;103:500–506. doi: 10.1182/blood-2003-01-0275
   PubMed Web of Science ®Google Scholar
• Chang M, Nakagawa PA, Williams SA, et al. Immune thrombocytopenic purpura (ITP) plasma and purified ITP monoclonal autoantibodies inhibit megakaryocytopoiesis in vitro. Blood. 2003;102:887–895. doi: 10.1182/blood-2002-05-1475
   PubMed Web of Science ®Google Scholar
• McMillan R, Wang L, Tomer A, et al. Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP. Blood. 2004;103:1364–1369. doi: 10.1182/blood-2003-08-2672
   PubMed Web of Science ®Google Scholar
• Portielje JE, Westendorp RG, Kluin-Nelemans HC, et al. Morbidity and mortality in adults with idiopathic thrombocytopenic purpura. Blood. 2001;97:2549–2554. doi: 10.1182/blood.V97.9.2549
   PubMed Web of Science ®Google Scholar
• Kuter DJ, Bussel JB, Lyons RM, et al. Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial. Lancet. 2008;371:395–403. doi: 10.1016/S0140-6736(08)60203-2
   PubMed Web of Science ®Google Scholar
• Kuter DJ, Rummel M, Boccia R, et al. Romiplostim or standard of care in patients with immune thrombocytopenia. N Engl J Med. 2010;363:1889–1899. doi: 10.1056/NEJMoa1002625
   PubMed Web of Science ®Google Scholar
• Bussel JB, Provan D, Shamsi T, et al. Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial. Lancet. 2009;373:641–648. doi: 10.1016/S0140-6736(09)60402-5
   PubMed Web of Science ®Google Scholar
• Arnold DM, Dentali F, Crowther MA, et al. Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura. Ann Intern Med. 2007;146:25–33. doi: 10.7326/0003-4819-146-1-200701020-00006
   PubMed Web of Science ®Google Scholar
• Cines DB, Bussel JB. How I treat idiopathic thrombocytopenic purpura (ITP). Blood. 2005;106:2244–2251. doi: 10.1182/blood-2004-12-4598
   PubMed Web of Science ®Google Scholar
• Blanchette V, Imbach P, Andrew M, et al. Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura. Lancet. 1994;344:703–707. doi: 10.1016/S0140-6736(94)92205-5
   PubMed Web of Science ®Google Scholar
• Mazzucconi MG, Fazi P, Bernasconi S, et al. Therapy with high-dose dexamethasone (HD-DXM) in previously untreated patients affected by idiopathic thrombocytopenic purpura: a GIMEMA experience. Blood. 2007;109:1401–1407. doi: 10.1182/blood-2005-12-015222
   PubMed Web of Science ®Google Scholar
• Kojouri K, Vesely SK, Terrell DR, et al. Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications. Blood. 2004;104:2623–2634. doi: 10.1182/blood-2004-03-1168
   PubMed Web of Science ®Google Scholar
• Godeau B, Porcher R, Fain O, et al. Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 study. Blood. 2008;112:999–1004. doi: 10.1182/blood-2008-01-131029
   PubMed Web of Science ®Google Scholar
• Zaja F, Baccarani M, Mazza P, et al. Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia. Blood. 2010;115:2755–2762. doi: 10.1182/blood-2009-07-229815
   PubMed Web of Science ®Google Scholar
• George JN, Woolf SH, Raskob GE, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood. 1996;88:3–40.
   PubMed Web of Science ®Google Scholar
• Provan D, Stasi R, Newland AC, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010;115:168–186. doi: 10.1182/blood-2009-06-225565
   PubMed Web of Science ®Google Scholar
• Sanz MÁ, Vicente García V, Fernández A, et al. [Guidelines for diagnosis, treatment and monitoring of primary immune thrombocytopenia]. Med Clínica. 2012;138:261.e1–261.e17.
   PubMed Web of Science ®Google Scholar
• Ferri consultor clinico, 2006–2007 : Claves diagnosticas y tratamiento [Internet]. [cited 2014 Mar 13]. Available from: http://www.agapea.com/libros/Ferri-consultor-clinico-2006-2007-claves-diagnosticas-y-tratamiento-9788481749144-i.htm
   Google Scholar
• Hedman A, Henter JI, Hedlund I, et al. Prevalence and treatment of chronic idiopathic thrombocytopenic purpura of childhood in Sweden. Acta Paediatr. 1997;86:226–227. doi: 10.1111/j.1651-2227.1997.tb08876.x
   PubMed Web of Science ®Google Scholar
• Hemoterapia AE de HY, Médicos E. Libro blanco de la hematología y hemoterapia en España. Sociedad Española de Hematol y Hemoterapia. 2012. p. 264.
   Google Scholar
• Grimaldi-Bensouda L, Michel M, Aubrun E, et al. A case-control study to assess the risk of immune thrombocytopenia associated with vaccines. Blood. 2012;120:4938–4944. doi: 10.1182/blood-2012-05-431098
   PubMed Web of Science ®Google Scholar
• Jensen AO, Nørgaard M, Engebjerg MC, et al. Predictors for splenectomy among patients with primary chronic immune thrombocytopenia: a population-based cohort study from Denmark. Ann Hematol. 2011;90:207–212. doi: 10.1007/s00277-010-1047-5
   PubMed Web of Science ®Google Scholar
• Kurata Y, Fujimura K, Kuwana M, et al. Epidemiology of primary immune thrombocytopenia in children and adults in Japan: a population-based study and literature review. Int J Hematol. 2011;93:329–335. doi: 10.1007/s12185-011-0791-1
   PubMed Web of Science ®Google Scholar
• Newton JL, Reese JA, Watson SI, et al. Fatigue in adult patients with primary immune thrombocytopenia. Eur J Haematol. 2011;86:420–429. doi: 10.1111/j.1600-0609.2011.01587.x
   PubMed Web of Science ®Google Scholar
• Kuhne T, Berchtold W, Michaels LA, et al. Newly diagnosed immune thrombocytopenia in children and adults: a comparative prospective observational registry of the Intercontinental Cooperative Immune Thrombocytopenia Study Group. Haematologica. 2011;96:1831–1837. doi: 10.3324/haematol.2011.050799
   PubMed Web of Science ®Google Scholar